-
2
pages
-
English
-
Documents
Description
Clinical Phase Ia Trial on MIV-711 Complete and Phase Ib Trial Commences PR Newswire STOCKHOLM, Sweden, August 21, 2012 STOCKHOLM, Sweden, August 21, 2012 /PRNewswire/ -- Medivir AB (OMX: MVIR), the research-based pharmaceutical company focused on the development of high-value treatments for
-
Publié par
-
Langue
English